Mr. Phelim Devine:

That is correct. We have set out a programme to meet the BAM programme in January 2024 and then the operational commissioning phase after that. We set the programme for that reason. We are procuring things we know will not change or innovate now and getting ready. As regards things that we know probably will innovate, we are working closely with CHI and its clinicians. We are trying to leave that as late as possible so that we get the best product.